Press Releases Year None202120202019201820172016 Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences November 16, 2021 PDF Version View HTML Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update November 15, 2021 PDF Version View HTML Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel November 11, 2021 PDF Version View HTML Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting November 9, 2021 PDF Version View HTML Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast November 8, 2021 PDF Version View HTML Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting November 4, 2021 PDF Version View HTML Gamida Cell Presents Data on its NAM-Enabled NK Cell Therapies at Protein & Antibody Engineering Summit (PEGS) Europe November 4, 2021 PDF Version View HTML Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day October 26, 2021 PDF Version View HTML Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting October 19, 2021 PDF Version View HTML Gamida Cell to Host Virtual Event Highlighting GDA-201 and NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline September 28, 2021 PDF Version View HTML Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 30
